{
    "eid": "2-s2.0-84957973280",
    "title": "Chemotherapeutic agents for patients with endometrial cancer",
    "cover-date": "2014-10-01",
    "subject-areas": [],
    "keywords": [],
    "authors": [
        "Siriwan Tangjitgamol"
    ],
    "citedby-count": 0,
    "ref-count": 101,
    "ref-list": [
        "Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: A gynecologic oncology group study",
        "Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer",
        "Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the grupo ginecologico Espa\u00f1ol para el tratamiento oncologico (GGETO)",
        "Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group study",
        "Hexamethylmelamine chemotherapy for disseminated endometrial cancer",
        "A phase II study of Cis-platinum for recurrent corpus cancer",
        "Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma",
        "Phase II evaluation of carboplatin in advanced endometrial carcinoma",
        "Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin",
        "Carboplatin therapy in advanced endometrial cancer",
        "Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group",
        "A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group Study",
        "Phase II trial of docetaxel in advanced or metastatic endometrial cancer: A Japanese Cooperative Study",
        "Clinical outcome of docetaxel in advanced or metastatic endometrial cancer",
        "Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: A randomized phase II study of the EORTC Gynecological Cancer Cooperative Group",
        "A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium",
        "A phase II study of ifosfamide in endometrial cancer",
        "Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93",
        "A phase II trial of vincristine in advanced or recurrent endometrial carcinoma",
        "A phase II trial of vinblastine in patients with advanced or recurrent endometrial carcinoma. A Southwest Oncology Group study",
        "Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin memorial sloan-kettering cancer center experience from 1995 to 2009",
        "Phase 2 trial of nonpegylated doxorubicin (Myocet) as second-line treatment in advanced or recurrent endometrial cancer",
        "Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: A gynecologic oncology group study",
        "Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy",
        "Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A gynecologic oncology group study",
        "Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study",
        "Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer",
        "Taxol is active in platinum-resistant endometrial adenocarcinoma",
        "Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study",
        "A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer",
        "A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: A study by the Gynecologic Oncology Group",
        "A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study",
        "Phase II study of Ifosfamide and Mesna in refractory adenocarcinoma of the endometrium",
        "A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: A gynecologic oncology group study",
        "Dactinomycin in the treatment of recurrent or persistent endometrial carcinoma: A Phase II Study of the Gynecologic Oncology Group",
        "Vincristine infusion in refractory gynecologic malignancies",
        "Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: A gynecologic oncology group study",
        "Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: A gynecologic oncology group study",
        "A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study",
        "Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group",
        "Proceedings of the American Society of Clinical Oncology",
        "Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study",
        "Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: A gynecologic oncology group study",
        "Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: A gynecologic oncology group study",
        "Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study",
        "Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium",
        "Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: A Japanese Gynecologic Oncology Group study (JGOG2041)",
        "Gynecol Oncol",
        "Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma",
        "A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: Preliminary report",
        "Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study",
        "Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: A phase II study of the Southwest Oncology Group",
        "Carboplatin and paclitaxel in advanced or metastatic endometrial cancer",
        "Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma",
        "A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: A Kansai Clinical Oncology Group study (KCOG0015 trial)",
        "Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma",
        "Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer? A gynecologic oncology group ancillary data analysis",
        "Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin",
        "Applicability of the concept of \"platinum sensitivity\" to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study",
        "Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study",
        "A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study",
        "Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial",
        "Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis",
        "Long-term outcomes after pelvic radiation for early-stage endometrial cancer",
        "Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study",
        "A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study",
        "Surgically staged high-risk endometrial cancer: Randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy",
        "Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: Results of a randomised trial",
        "Adjuvant chemotherapy including cisplatin in endometrial carcinoma",
        "Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study",
        "Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-Results from two randomised studies",
        "J Clin Oncol",
        "Gynecol Oncol",
        "Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study",
        "Proceedings of the 13th International Gynecologic Cancer Society",
        "A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus",
        "Adjuvant chemotherapy for endometrial cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Navamindradhiraj University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}